An 80-year-old woman with advanced Alzheimer's regained speech and mobility after taking psilocybin
An 80-year-old woman with Alzheimer's has regained speech and mobility after taking psilocybin.
📍 Aftermath
A single-person study found that an 80-year-old woman with advanced Alzheimer's showed functional improvements after taking psilocybin. The woman regained speech, memory, and mobility, which surprised researchers.
The case was presented as a research hypothesis rather than a treatment recommendation.
Epilogue added 21d ago, after coverage quieted.
The brief
An 80-year-old woman with advanced Alzheimer's disease has reportedly regained speech and mobility after taking psilocybin. The woman, who had previously lost the ability to speak and move, began conversing and moving again following the treatment.
Coverage emphasizes the unexpected recovery of speech and mobility in a patient with advanced Alzheimer's. The story is featured in Techno-Science.net, ZME Science, New Scientist, and PsyPost.
Watch for further developments in psilocybin research and its potential applications in treating Alzheimer's disease. Coverage does not yet specify the context or setting of the treatment.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 32d ago.
Sources (10)
- Woman with Alzheimer’s shows improvements after taking magic mushrooms in single-person study CP24 · 32d ago
- Woman with Alzheimer’s shows improvements after taking magic mushrooms in single-person study CTV News · 32d ago
- Woman with late-stage Alzheimer’s showed ‘functional improvements’ after taking psilocybin dosage, study finds CP24 · 32d ago
- Severe Alzheimer’s: what happened after a dose of psilocybin surprised researchers Futura, le média qui explore le monde · 32d ago
- Woman with late-stage Alzheimer’s showed ‘functional improvements’ after taking psilocybin dosage, study finds CTV News · 32d ago
- A Research Hypothesis, Not A Treatment Recommendation: Marcos Lago on the Viral Psilocybin for Alzheimer's Case Report Psychedelic Alpha · 32d ago
- 🍄 An octogenarian regains speech and memory after taking hallucinogenic mushrooms Techno-Science.net · 32d ago
- A Woman With Advanced Alzheimer’s Took Magic Mushrooms and Started Speaking Again ZME Science · 32d ago
- Woman with Alzheimer's starts conversing again after taking psilocybin New Scientist · 32d ago
- An 80-year-old woman with advanced Alzheimer's regained speech and mobility after taking psilocybin PsyPost · 32d ago
Quick answers
What is psilocybin?
Psilocybin is a naturally occurring psychedelic compound found in certain types of mushrooms.
What is Alzheimer's disease?
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink and brain cells to die. It is the most common cause of dementia.
What is the significance of this case?
This case is significant because it suggests that psilocybin may have potential therapeutic benefits for patients with advanced Alzheimer's disease.
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
UK doctors say breakthrough in Alzheimer’s research may have found way to restore sleep
A newly identified brain mechanism could finally let doctors restore sleep in Alzheimer’s patients.
Magic mushrooms may reshape the brain long after the trip ends
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Alzheimer’s breakthrough: Scientists restore two hours of sleep without clearing brain plaques
Researchers have achieved a breakthrough in Alzheimer's treatment by restoring two hours of nightly sleep without targeting brain plaques.
Scientists discover a protein that protects the brain from Alzheimer’s damage
Scientists have identified the SORLA protein as a potential defense mechanism against Alzheimer's disease and toxic tau tangles.
Alzheimer's: Real-world study confirms Leqembi therapy benefits
FDA approval of an at-home subcutaneous starter dose for Leqembi coincides with a real-world study confirming the therapy's benefits.
Rare Autopsy Finds Alzheimer's Drugs Only Work in Some Parts of The Brain
New clinicopathologic research indicates that Alzheimer's drugs targeting amyloid plaques exhibit varying efficacy across different regions of the brain.